Apellis Pharmaceuticals Inc (APLS)
41.92
+0.72
(+1.75%)
USD |
NASDAQ |
May 15, 16:00
42.20
+0.28
(+0.67%)
Pre-Market: 20:00
Apellis Pharmaceuticals Shares Outstanding: 121.37M for May 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| May 01, 2024 | 121.37M |
| April 08, 2024 | 121.29M |
| March 31, 2024 | 121.26M |
| February 20, 2024 | 120.58M |
| December 31, 2023 | 119.56M |
| October 24, 2023 | 118.50M |
| September 30, 2023 | 118.36M |
| July 24, 2023 | 117.74M |
| June 30, 2023 | 117.58M |
| May 01, 2023 | 116.46M |
| April 03, 2023 | 116.18M |
| March 31, 2023 | 116.18M |
| February 27, 2023 | 115.30M |
| February 15, 2023 | 111.29M |
| December 31, 2022 | 110.77M |
| November 01, 2022 | 110.58M |
| September 30, 2022 | 110.48M |
| August 04, 2022 | 109.87M |
| August 01, 2022 | 108.86M |
| June 30, 2022 | 106.84M |
| April 29, 2022 | 106.52M |
| April 05, 2022 | 106.47M |
| March 31, 2022 | 106.44M |
| March 28, 2022 | 106.30M |
| February 23, 2022 | 97.73M |
| Date | Value |
|---|---|
| December 31, 2021 | 97.52M |
| November 18, 2021 | 97.36M |
| November 02, 2021 | 87.30M |
| September 30, 2021 | 87.22M |
| August 03, 2021 | 87.00M |
| July 23, 2021 | 86.49M |
| June 30, 2021 | 80.96M |
| April 23, 2021 | 80.50M |
| April 05, 2021 | 80.44M |
| March 31, 2021 | 80.44M |
| February 22, 2021 | 80.38M |
| January 26, 2021 | 79.64M |
| December 31, 2020 | 76.13M |
| October 28, 2020 | 75.74M |
| September 30, 2020 | 75.70M |
| July 27, 2020 | 75.60M |
| June 30, 2020 | 75.60M |
| April 24, 2020 | 75.51M |
| April 13, 2020 | 75.50M |
| March 31, 2020 | 75.40M |
| February 21, 2020 | 75.32M |
| January 13, 2020 | 74.86M |
| December 31, 2019 | 63.94M |
| November 01, 2019 | 63.89M |
| September 30, 2019 | 63.87M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
63.67M
Minimum
Jun 30 2019
121.37M
Maximum
May 01 2024
94.26M
Average
97.36M
Median
Nov 18 2021
Shares Outstanding Benchmarks
| Blueprint Medicines Corp | 62.62M |
| Sarepta Therapeutics Inc | 94.52M |
| Inspire Medical Systems Inc | 29.71M |
| Alnylam Pharmaceuticals Inc | 126.49M |
| Biomarin Pharmaceutical Inc | 189.88M |